Condition deep-dive · 6 min read

Adult acne — supplement adjuncts to dermatological care

Updated 2026-05-12 · Reviewed by SupplementScore editors · No sponsorships

Adult acne — persistent or new-onset acne in patients over their early 20s — is increasingly common, particularly in women, and often hormonally influenced. The medical mainstays (topical retinoids, benzoyl peroxide, topical antibiotics, hormonal therapy in women, oral isotretinoin for severe disease) produce clearance rates no supplement matches. Supplements come in as targeted adjuncts: zinc (with the most direct trial support), omega-3 for inflammatory subtypes, and dietary-pattern modification for high-glycaemic-load triggers. The framework is adjunct to dermatology care, not a replacement.

Read this first. Persistent adult acne, particularly with cystic or scarring lesions, deserves dermatology evaluation. New-onset acne in adult women with hirsutism, irregular cycles, or weight gain should prompt PCOS evaluation. Self-treatment with supplements alone in moderate-to-severe disease delays effective treatment and risks scarring.

Supplement adjuncts with mechanism and trial signals

Tier 1 evidence (within supplements) · Best-evidenced supplement for acne

Zinc (gluconate or picolinate)

30 mg elemental zinc/day for 8–12 weeks; cap at 40 mg/day total; reassess and consider copper 1–2 mg/day on chronic use

Zinc gluconate at 30 mg/day has shown non-inferiority to minocycline for inflammatory acne in multiple trials (Dreno 2001). Mechanism likely involves anti-inflammatory and antibacterial effects on Cutibacterium acnes. Picolinate is preferred in dermatology trials. Trial period 8–12 weeks; long-term use requires copper supplementation to prevent depletion.

Tier 2 evidence · For inflammatory acne subtypes

Omega-3 (EPA/DHA)

1–3 g EPA+DHA daily with meals; choose third-party-tested form

Several small RCTs show modest improvements in inflammatory acne lesion counts with high-dose omega-3 supplementation. Mechanism via reduced inflammatory eicosanoid production. Effect size smaller than topical retinoids but useful as adjunct, particularly in inflammatory-dominant disease.

Tier 2 evidence · For users with low-grade insulin resistance / PCOS overlap

Myo-inositol (with or without D-chiro-inositol)

2 g myo-inositol twice daily for 12+ weeks; 40:1 myo:DCI ratio in some PCOS protocols

For acne in adult women with concurrent PCOS, insulin resistance, or hyperandrogenism, myo-inositol improves the insulin-resistance metabolic substrate and modestly reduces androgen-mediated acne. Not first-line for acne alone; appropriate when metabolic features are present.

Tier 3 evidence · For users with Demodex-associated or fungal-overlap acneform eruptions

Selected probiotic strains

Lactobacillus / Bifidobacterium multi-strain formula for 8–12 weeks; reassess

Small studies suggest selected probiotic strains may reduce inflammatory acne lesion counts, possibly via gut-skin axis effects. Evidence is preliminary; reasonable adjunct in users with concurrent gut symptoms.

Tier 3 evidence · Where deficient

Vitamin D3 (to a target)

Test 25-OH-D and supplement to 30–50 ng/mL; typical maintenance 1,000–2,000 IU/day

Observational associations between low vitamin D and acne severity exist; trial evidence for direct supplementation effect is limited. Test and correct deficiency rather than empirical megadosing.

What to skip — supplements commonly marketed for acne that don't deliver

High-dose biotin — no evidence base for acne; can worsen acne in some users via altered B-vitamin balance; interferes with thyroid and troponin assays.
Vitamin B12 high-dose — has triggered acneiform eruptions in case reports; avoid high-dose B12 supplementation in active acne unless treating documented deficiency.
"Hormonal balance" herbal stacks for women — typically contain inconsistent doses of vitex, dong quai, black cohosh; under-trialled for acne specifically; risk of disrupting other hormonal therapies.
"Detox" / "liver cleanse" supplements — acne is not a liver-detox disorder; mechanism doesn't apply.
Iodine supplementation — high iodine intake can trigger acneiform eruptions; avoid kelp or high-iodine supplements unless treating documented deficiency.
Whey protein in users with persistent acne — observational data suggest whey may worsen acne in susceptible users via IGF-1 signalling; consider trial period off whey if acne persists despite optimised dermatology care.
"Acne supplement" multi-ingredient formulas at premium prices — typically under-dose every active ingredient.

The dietary layer with real signal

Low-glycaemic-load eating pattern — multiple trials show low-GL diets reduce acne lesion counts. The Smith 2007 trial in male teens showed clear improvements; subsequent meta-analyses align.
Reduced dairy intake — skim milk in particular is associated with acne in cohort studies. Trial removal for 8–12 weeks if persistent acne despite dermatology care.
Reduced whey protein and high-IGF-1-stimulating foods — same mechanism; relevant in athletes with persistent acne.

The dermatology layer that dominates everything

Topical retinoids (tretinoin, adapalene, tazarotene) — first-line; nightly application with gradual ramp-up.
Topical benzoyl peroxide 2.5–10% — reduces bacterial load; pairs well with retinoids.
Topical antibiotics (clindamycin, erythromycin) — short courses combined with BPO to limit resistance.
Oral hormonal therapy in women (combined OCPs, spironolactone) — for hormonally-driven adult female acne.
Oral isotretinoin — for moderate-to-severe nodulocystic disease or recalcitrant disease; dermatologist-managed.

Practical quick-start. Coordinate the dermatology protocol — topical retinoid + BPO is first-line. Add zinc 30 mg/day for 8–12 weeks as the highest-evidence supplement adjunct. Consider omega-3 1–2 g EPA+DHA daily for inflammatory subtypes. Adopt a low-glycaemic-load eating pattern. Trial removing skim milk and whey if acne persists despite optimised dermatology care. Get evaluation for PCOS / hormonal drivers in adult women with new-onset or persistent acne plus other hyperandrogen features.

What to track

Lesion count and severity (IGA — Investigator Global Assessment) at baseline and follow-up. Photos at standardised lighting and distance. For users with hormonal features: cycle history, total/free testosterone, DHEAS, SHBG, 17-OH-progesterone (with prescriber). For users on isotretinoin: monthly liver function, lipid panel, pregnancy testing per iPLEDGE protocol. For users on chronic zinc above 30 mg/day: serum copper at 6 months.